The invention is under the field of hemostatic products use for direct pressure to stop external bleeding.
To stop external bleeding from relatively superficial causes, 4×4s (gauze) are generally use to apply direct pressure to the bleeding site. This is usually adequate. However, in cases where there is high pressure (like bleeding from an artery) or an anticoagulant was administered during a medical procedure or therapy (e.g. hemodialysis and cardiac catheterization), the bleeding is prolonged and applying direct pressure using 4×4s (gauze) becomes inefficient.
In hemodialysis, a large vein (arteriovenous (AV) fistula) or artificial vessel (arteriovenous (AV) graft) is joined to an artery. These become an access site where blood is drawn—to be filtered through the dialysis machine—and returned. Being joined to an artery, the AV fistula and AV graft have high pressure. During the treatment, blood thinner is administered to prevent clotting of blood in the dialysis lines. After the treatment, the large bore dialysis needles are removed and direct pressure using 4×4s (gauze) is applied to the area. Because of high pressure in the access site and blood thinner administered during treatment, bleeding is usually prolonged. This results to a lot of 4×4s (gauze) used, a lot of blood loss, and a lot of time spent—both the personnel's and the patient's. Layers of 4×4 (gauze) put on to the bleeding site make it difficult to apply effective pressure. Constant changing of the 4×4s (gauze) also contributes to prolonged bleeding.
The human factor of inconsistent application of pressure adds to the problem of prolonged bleeding in dialysis, aggravated by the fact that an access site may also move from side to side and thus reducing the pressure applied.
From the foregoing, it is seen that it is a problem in the art to provide a device meeting the above requirements. According to the present invention, a device and process are provided which meets the aforementioned requirements and needs in the prior art.
Specifically, the device according to the present invention is designed for consistent and effective pressure applied to the bleeding site, eliminating the human factor. It also stabilizes a movable hemodiaysis access. In most cases, with the design that included an adhesive band, it can be applied and left alone freeing the medical personnel to do other things. Generally, it speeds up stoppage of bleeding.
The invention is a device designed to stop bleeding from various sources, particularly the following:
Other objects and advantages of the present invention will be more readily apparent from the following detailed description when read in conjunction with the accompanying drawings.
The dome-shaped portion 30 and the absorbent portion 20 are shown in further detail in
In use, the strip portion 10 is applied over a desired location with the adhesive surface facing down so that the adhesive surface can contact surrounding tissue so as to secure the coaguband 100 to the tissue over the desired location, and so that the dome-shaped portion 30 is urged downwardly against the desired location so as to force the absorbent portion 20 directly into contact with the desired location.
The Coaguband 100 is a device for applying direct pressure on a bleeding site. It has an adhesive band 10, an absorbent portion 20 having in its center the dome-shaped rubber or plastic component 20. The band 10 anchors the device 100 on the bleeding site at the same time applying pressure on it, while the dome-shaped component 30 multiplies the pressure exerted by the band 10. The absorbent portion 20 absorbs unclotted blood. The coaguband 100 design makes for a more efficient device for stopping bleeding than the traditional method of a medical personnel applying pressure with 4×4 (gauze). In most cases, with its dome-shaped component 30 multiplying the pressure exerted by its adhesive band 10, it effectively replaces the human thumb in applying direct pressure on a bleeding site, freeing the medical personnel for other duties.
The coaguband 100 is a hemostatic device which has a dome-shaped rubber or plastic component 30 that is enclosed in an absorbent portion 20. The sizes vary for the intended usage, as follows:
A further embodiment of the invention will have the hemostatic device 100 fastened to an adhesive band which also differs in size—both in width and length—and in the nature of components.
At the center of the adhesive band 10 is a dome-shaped plastic or rubber component 30, which is enclosed by the absorbent portion 20. In
The adhesive portion 10 forms a band, and anchors the coaguband 100 on the bleeding site. This adhesive portion 10 can be relatively short, comparable to a regular size “Band Aid”, or this can be relatively long and capable of wrapping around a patient's arm. The short version of the adhesive portion 10 can be used for light to medium bleeding. The longer version of the adhesive portion can apply more pressure and can be used for medium to heavy bleeding.
The dome-shaped rubber or plastic component 30 multiplies the pressure applied on the bleeding site by the adhesive. This also stabilizes a movable dialysis access site (fistula or graft), preventing it from moving out of the point of pressure.
The absorbent portion 20 absorbs the blood efficiently, and can be composed of any known type of absorbent material known in the medical or dental arts for use with bleeding.
Advantages:
The article of
The invention being thus described, it will be evident that the same may be varied in many ways. Such variations are not to be regarded as a departure from the spirit and scope of the invention and all such modifications are intended to be included within the scope of the claims.
This application claims the priority of U.S. patent application Ser. No. 61/741,058 filed on Jul. 11, 2012, Inventor Lydda R. Domingo, entitled “Pressure Application for Hemostatis.” The entire disclosure of this aforementioned provisional patent application is hereby incorporated in its entirety by reference thereto.
Number | Date | Country | |
---|---|---|---|
61741085 | Jul 2012 | US |